ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009